Clinical trial
A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)
NCT01445626 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- January 31, 2012
- Enrollment
- 87 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.